{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:13:32Z","timestamp":1784085212208,"version":"3.55.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-08105-x","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:22:05Z","timestamp":1759314125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["First trimester maternal serum MicroRNA expression and pre-eclampsia: a retrospective nested case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Paula L.","family":"Hedley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin Olesen","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"W\u00f8jdemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Cathrine","family":"Shalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Placing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Rode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Cathrine","family":"Gjerris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Sundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Tabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"Suppl 1","key":"8105_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, et al. The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):1\u201333.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"8105_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1067\/mob.2000.107928","volume":"183","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy*","year":"2000","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy*. Report of the National high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1\u201322.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"8105_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"14","key":"8105_CR4","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","volume":"76","author":"CW Ives","year":"2020","unstructured":"Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and clinical presentations: JACC State-of-the-Art review. J Am Coll Cardiol. 2020;76(14):1690\u2013702.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"8105_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"LA Magee","year":"2022","unstructured":"Magee LA, Nicolaides KH. Von Dadelszen P: preeclampsia. N Engl J Med. 2022;386(19):1817\u201332.","journal-title":"N Engl J Med"},{"issue":"2S","key":"8105_CR6","doi-asserted-by":"publisher","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","volume":"226","author":"DL Rolnik","year":"2022","unstructured":"Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226(2S):S1108\u201319.","journal-title":"Am J Obstet Gynecol"},{"issue":"10297","key":"8105_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341\u201354.","journal-title":"Lancet"},{"issue":"18","key":"8105_CR8","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","volume":"75","author":"VD Garovic","year":"2020","unstructured":"Garovic VD, White WM, Vaughan L, Saiki M, Parashuram S, Garcia-Valencia O, Weissgerber TL, Milic N, Weaver A, Mielke MM. Incidence and Long-Term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020;75(18):2323\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"8105_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"8105_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.preghy.2012.11.001","volume":"3","author":"AL Tranquilli","year":"2013","unstructured":"Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The definition of severe and early-onset preeclampsia. Statements from the international society for the study of hypertension in pregnancy (ISSHP). Pregnancy Hypertens. 2013;3(1):44\u20137.","journal-title":"Pregnancy Hypertens"},{"issue":"9","key":"8105_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41574-020-0372-6","volume":"16","author":"JD Aplin","year":"2020","unstructured":"Aplin JD, Myers JE, Timms K, Westwood M. Tracking placental development in health and disease. Nat Rev Endocrinol. 2020;16(9):479\u201394.","journal-title":"Nat Rev Endocrinol"},{"issue":"2S","key":"8105_CR12","doi-asserted-by":"publisher","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","volume":"226","author":"P Chaemsaithong","year":"2022","unstructured":"Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226(2S):S1071\u2013Se10971072.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"8105_CR13","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","volume":"132","author":"ACOG Committee Opinion No","year":"2018","unstructured":"ACOG Committee Opinion No. 743: Low-Dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44\u201352.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"8105_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/uog.19112","volume":"52","author":"MY Tan","year":"2018","unstructured":"Tan MY, Syngelaki A, Poon LC, Rolnik DL, O\u2019Gorman N, Delgado JL, Akolekar R, Konstantinidou L, Tsavdaridou M, Galeva S, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2018;52(2):186\u201395.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"8105_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajog.2018.11.1087","volume":"220","author":"D Wright","year":"2019","unstructured":"Wright D, Tan MY, O\u2019Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH. Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol. 2019;220(2):199. e191-199 e113.","journal-title":"Am J Obstet Gynecol"},{"key":"8105_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.","journal-title":"Front Endocrinol"},{"issue":"4","key":"8105_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","volume":"30","author":"MA Mori","year":"2019","unstructured":"Mori MA, Ludwig RG, Garcia-Martin R, Brandao BB, Kahn CR. Extracellular mirnas: from biomarkers to mediators of physiology and disease. Cell Metab. 2019;30(4):656\u201373.","journal-title":"Cell Metab"},{"issue":"3\u20134","key":"8105_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.proghi.2016.06.001","volume":"51","author":"JA Makarova","year":"2016","unstructured":"Makarova JA, Shkurnikov MU, Wicklein D, Lange T, Samatov TR, Turchinovich AA, Tonevitsky AG. Intracellular and extracellular microrna: an update on localization and biological role. Prog Histochem Cytochem. 2016;51(3\u20134):33\u201349.","journal-title":"Prog Histochem Cytochem"},{"key":"8105_CR19","unstructured":"Homo sapiens miRNAs. https:\/\/www.mirbase.org\/summary.shtml?org=hsa."},{"issue":"2","key":"8105_CR20","first-page":"175","volume":"10","author":"MH Sohel","year":"2016","unstructured":"Sohel MH. Extracellular\/Circulating micrornas: release mechanisms, functions and challenges. Achiev Life Sci. 2016;10(2):175\u201386.","journal-title":"Achiev Life Sci"},{"issue":"12","key":"8105_CR21","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, et al. Argonaute2 complexes carry a population of Circulating MicroRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108(12):5003\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"8105_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13(4):423\u201333.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"8105_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.tibs.2012.08.003","volume":"37","author":"A Turchinovich","year":"2012","unstructured":"Turchinovich A, Weiz L, Burwinkel B. Extracellular mirnas: the mystery of their origin and function. Trends Biochem Sci. 2012;37(11):460\u20135.","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"8105_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells9020276","volume":"9","author":"CE Condrat","year":"2020","unstructured":"Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, Cretoiu D, Suciu N, Cretoiu SM, Voinea SC. MiRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells. 2020;9(2):276.","journal-title":"Cells"},{"issue":"4","key":"8105_CR25","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.3390\/ijms22042158","volume":"22","author":"EE Burkova","year":"2021","unstructured":"Burkova EE, Sedykh SE, Nevinsky GA. Human placenta exosomes: biogenesis, isolation, composition, and prospects for use in diagnostics. Int J Mol Sci. 2021;22(4):2158.","journal-title":"Int J Mol Sci"},{"key":"8105_CR26","doi-asserted-by":"publisher","first-page":"8067972","DOI":"10.1155\/2017\/8067972","volume":"2017","author":"M Barchitta","year":"2017","unstructured":"Barchitta M, Maugeri A, Quattrocchi A, Agrifoglio O, Agodi A. The role of MiRNAs as biomarkers for pregnancy outcomes: A comprehensive review. Int J Genomics. 2017;2017:8067972.","journal-title":"Int J Genomics"},{"issue":"1","key":"8105_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/jog.14150","volume":"46","author":"X Han","year":"2020","unstructured":"Han X, Niu C, Zuo Z, Wang Y, Yao L, Sun L. MiR-342-3p Inhibition promotes cell proliferation and invasion by directly targeting ID4 in pre-eclampsia. J Obstet Gynaecol Res. 2020;46(1):49\u201357.","journal-title":"J Obstet Gynaecol Res"},{"key":"8105_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.preghy.2019.04.004","volume":"17","author":"M Hocaoglu","year":"2019","unstructured":"Hocaoglu M, Demirer S, Senturk H, Turgut A, Komurcu-Bayrak E. Differential expression of candidate Circulating MicroRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus. Pregnancy Hypertens. 2019;17:5\u201311.","journal-title":"Pregnancy Hypertens"},{"issue":"12","key":"8105_CR29","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.3390\/ijms20122972","volume":"20","author":"I Hromadnikova","year":"2019","unstructured":"Hromadnikova I, Dvorakova L, Kotlabova K, Krofta L. The prediction of gestational hypertension, preeclampsia and fetal growth restriction via the first trimester screening of plasma Exosomal C19MC MicroRNAs. Int J Mol Sci. 2019;20(12):2972.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8105_CR30","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1161\/HYPERTENSIONAHA.119.14081","volume":"75","author":"H Li","year":"2020","unstructured":"Li H, Ouyang Y, Sadovsky E, Parks WT, Chu T, Sadovsky Y. Unique MicroRNA signals in plasma exosomes from pregnancies complicated by preeclampsia. Hypertension. 2020;75(3):762\u201371.","journal-title":"Hypertension"},{"key":"8105_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejogrb.2021.06.032","volume":"263","author":"G Liao","year":"2021","unstructured":"Liao G, Cheng D, Li J, Hu S. Clinical significance of microRNA-320a and insulin-like growth factor-1 receptor in early-onset preeclampsia patients. Eur J Obstet Gynecol Reprod Biol. 2021;263:164\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"22","key":"8105_CR32","doi-asserted-by":"publisher","first-page":"e20319","DOI":"10.1097\/MD.0000000000020319","volume":"99","author":"C Sheng","year":"2020","unstructured":"Sheng C, Zhao Y, Zhu L. Down-regulation of EDN1 gene expression by Circulating miR-206 is associated with risk of preeclampsia. Medicine. 2020;99(22):e20319.","journal-title":"Medicine"},{"issue":"1","key":"8105_CR33","doi-asserted-by":"publisher","first-page":"18077","DOI":"10.1038\/s41598-020-73783-w","volume":"10","author":"CA Whigham","year":"2020","unstructured":"Whigham CA, MacDonald TM, Walker SP, Hiscock R, Hannan NJ, Pritchard N, Cannon P, Nguyen TV, Miranda M, Tong S, et al. MicroRNAs 363 and 149 are differentially expressed in the maternal circulation preceding a diagnosis of preeclampsia. Sci Rep. 2020;10(1):18077.","journal-title":"Sci Rep"},{"key":"8105_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jri.2015.03.005","volume":"110","author":"EE Winger","year":"2015","unstructured":"Winger EE, Reed JL, Ji X. First-trimester maternal cell MicroRNA is a superior pregnancy marker to immunological testing for predicting adverse pregnancy outcome. J Reprod Immunol. 2015;110:22\u201335.","journal-title":"J Reprod Immunol"},{"issue":"2","key":"8105_CR35","doi-asserted-by":"publisher","first-page":"e0171756","DOI":"10.1371\/journal.pone.0171756","volume":"12","author":"I Hromadnikova","year":"2017","unstructured":"Hromadnikova I, Kotlabova K, Ivankova K, Krofta L. First trimester screening of Circulating C19MC MicroRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR. PLoS ONE. 2017;12(2):e0171756.","journal-title":"PLoS ONE"},{"key":"8105_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.placenta.2017.02.001","volume":"51","author":"L Jiang","year":"2017","unstructured":"Jiang L, Long A, Tan L, Hong M, Wu J, Cai L, Li Q. Elevated microRNA-520\u00a0g in pre-eclampsia inhibits migration and invasion of trophoblasts. Placenta. 2017;51:70\u20135.","journal-title":"Placenta"},{"key":"8105_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.preghy.2017.04.002","volume":"10","author":"K Singh","year":"2017","unstructured":"Singh K, Williams J 3rd, Brown J, Wang ET, Lee B, Gonzalez TL, Cui J, Goodarzi MO, Pisarska MD. Up-regulation of microRNA-202-3p in first trimester placenta of pregnancies destined to develop severe preeclampsia, a pilot study. Pregnancy Hypertens. 2017;10:7\u20139.","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"8105_CR38","doi-asserted-by":"publisher","first-page":"e0190654","DOI":"10.1371\/journal.pone.0190654","volume":"13","author":"EE Winger","year":"2018","unstructured":"Winger EE, Reed JL, Ji X, Nicolaides K. Peripheral blood cell MicroRNA quantification during the first trimester predicts preeclampsia: proof of concept. PLoS ONE. 2018;13(1):e0190654.","journal-title":"PLoS ONE"},{"issue":"18","key":"8105_CR39","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1080\/14767058.2019.1569614","volume":"33","author":"E Devor","year":"2020","unstructured":"Devor E, Santillan D, Scroggins S, Warrier A, Santillan M. Trimester-specific plasma exosome MicroRNA expression profiles in preeclampsia. J Matern Fetal Neonatal Med. 2020;33(18):3116\u201324.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"8105_CR40","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.21873\/invivo.12044","volume":"34","author":"D Mavreli","year":"2020","unstructured":"Mavreli D, Lykoudi A, Lambrou G, Papaioannou G, Vrachnis N, Kalantaridou S, Papantoniou N, Kolialexi A. Deep sequencing identified dysregulated Circulating MicroRNAs in late onset preeclampsia. Vivo. 2020;34(5):2317\u201324.","journal-title":"Vivo"},{"key":"8105_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejogrb.2020.08.016","volume":"253","author":"Y Yin","year":"2020","unstructured":"Yin Y, Liu M, Yu H, Zhang J, Zhou R. Circulating MicroRNAs as biomarkers for diagnosis and prediction of preeclampsia: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;253:121\u201332.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"8105_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejmhg.2011.09.002","volume":"13","author":"H Harapan","year":"2012","unstructured":"Harapan H, Andalas M, Mudhakir D, Pedroza NC, Laddha SV, Anand JR. Micro RNA: new aspect in pathobiology of preeclampsia? Egypt J Med Hum Genet. 2012;13(2):127\u201331.","journal-title":"Egypt J Med Hum Genet"},{"issue":"3","key":"8105_CR43","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3892\/mmr.2016.4846","volume":"13","author":"DS Jairajpuri","year":"2016","unstructured":"Jairajpuri DS, Almawi WY. MicroRNA expression pattern in pre-eclampsia (Review). Mol Med Rep. 2016;13(3):2351\u20138.","journal-title":"Mol Med Rep"},{"issue":"5","key":"8105_CR44","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41430-021-01017-x","volume":"76","author":"P Kochhar","year":"2022","unstructured":"Kochhar P, Dwarkanath P, Ravikumar G, Thomas A, Crasta J, Thomas T, Kurpad AV, Mukhopadhyay A. Placental expression of miR-21-5p, miR-210-3p and miR-141-3p: relation to human fetoplacental growth. Eur J Clin Nutr. 2022;76(5):730\u20138.","journal-title":"Eur J Clin Nutr"},{"key":"8105_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cellsig.2018.12.006","volume":"55","author":"R Li","year":"2019","unstructured":"Li R, Wang N, Xue M, Long W, Cheng C, Mi C, Gao Z. A potential regulatory network among WDR86-AS1, miR-10b-3p, and LITAF is possibly involved in preeclampsia pathogenesis. Cell Signal. 2019;55:40\u201352.","journal-title":"Cell Signal"},{"key":"8105_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.placenta.2021.01.002","volume":"104","author":"Y Mao","year":"2021","unstructured":"Mao Y, Hou B, Shan L, Sun X, Wang L. Aberrantly up-regulated miR-142-3p inhibited the proliferation and invasion of trophoblast cells by regulating FOXM1. Placenta. 2021;104:253\u201360.","journal-title":"Placenta"},{"issue":"1","key":"8105_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40659-021-00351-5","volume":"54","author":"P Peng","year":"2021","unstructured":"Peng P, Song H, Xie C, Zheng W, Ma H, Xin D, Zhan J, Yuan X, Chen A, Tao J, et al. miR-146a-5p-mediated suppression on trophoblast cell progression and epithelial-mesenchymal transition in preeclampsia. Biol Res. 2021;54(1):30.","journal-title":"Biol Res"},{"issue":"1","key":"8105_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3892\/mmr.2016.5268","volume":"14","author":"ES Vashukova","year":"2016","unstructured":"Vashukova ES, Glotov AS, Fedotov PV, Efimova OA, Pakin VS, Mozgovaya EV, Pendina AA, Tikhonov AV, Koltsova AS, Baranov VS. Placental MicroRNA expression in pregnancies complicated by superimposed pre\u2013eclampsia on chronic hypertension. Mol Med Rep. 2016;14(1):22\u201332.","journal-title":"Mol Med Rep"},{"key":"8105_CR49","doi-asserted-by":"publisher","first-page":"104263","DOI":"10.1016\/j.yexmp.2019.104263","volume":"110","author":"D Wang","year":"2019","unstructured":"Wang D, Liu N, Tian Y, Li Y, Shen X, Chen Y, Wu F. Expression profile of Let-7s in peripheral blood mononuclear cells of normal and severe preeclampsia pregnant women. Exp Mol Pathol. 2019;110:104263.","journal-title":"Exp Mol Pathol"},{"key":"8105_CR50","doi-asserted-by":"publisher","first-page":"104618","DOI":"10.1016\/j.yexmp.2021.104618","volume":"119","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang Y, Li L, Mei J, Zhang X, Wu Z. Predictive value of 4-Hydroxyglutamate and miR-149-5p on eclampsia. Exp Mol Pathol. 2021;119:104618.","journal-title":"Exp Mol Pathol"},{"issue":"5","key":"8105_CR51","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1373\/clinchem.2011.179283","volume":"58","author":"Z Zhao","year":"2012","unstructured":"Zhao Z, Zhao Q, Warrick J, Lockwood CM, Woodworth A, Moley KH, Gronowski AM. Circulating MicroRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin Chem. 2012;58(5):896\u2013905.","journal-title":"Clin Chem"},{"issue":"3","key":"8105_CR52","doi-asserted-by":"publisher","first-page":"151527","DOI":"10.1016\/j.acthis.2020.151527","volume":"122","author":"F Gong","year":"2020","unstructured":"Gong F, Chai W, Wang J, Cheng H, Shi Y, Cui L, Jia G. miR-214-5p suppresses the proliferation, migration and invasion of trophoblast cells in pre-eclampsia by targeting Jagged 1 to inhibit Notch signaling pathway. Acta Histochem. 2020;122(3):151527.","journal-title":"Acta Histochem"},{"issue":"6","key":"8105_CR53","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1111\/jog.14732","volume":"47","author":"B Liu","year":"2021","unstructured":"Liu B, Liu L, Cui S, Qi Y, Wang T. Expression and significance of microRNA-126 and VCAM-1 in placental tissues of women with early-onset preeclampsia. J Obstet Gynaecol Res. 2021;47(6):2042\u201350.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"8105_CR54","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/jog.14451","volume":"47","author":"H Ni","year":"2021","unstructured":"Ni H, Wang X, Qu H, Gao X, Yu X. MiR-95-5p involves in the migration and invasion of trophoblast cells by targeting low density lipoprotein receptor-related protein 6. J Obstet Gynaecol Res. 2021;47(1):184\u201397.","journal-title":"J Obstet Gynaecol Res"},{"key":"8105_CR55","doi-asserted-by":"publisher","first-page":"108366","DOI":"10.1016\/j.abb.2020.108366","volume":"688","author":"L Zhao","year":"2020","unstructured":"Zhao L, Liang X, Ma Y, Li J, Liao S, Chen J, Wang C. AK002210 promotes the proliferation, migration and invasion of trophoblast cell through regulating miR-590\/NAIP signal axis. Arch Biochem Biophys. 2020;688:108366.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"8105_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/jog.14412","volume":"47","author":"L Han","year":"2021","unstructured":"Han L, Luo QQ, Peng MG, Zhang Y, Zhu XH. miR-483 is downregulated in pre-eclampsia via targeting insulin-like growth factor 1 (IGF1) and regulates the PI3K\/Akt\/mTOR pathway of endothelial progenitor cells. J Obstet Gynaecol Res. 2021;47(1):63\u201372.","journal-title":"J Obstet Gynaecol Res"},{"key":"8105_CR57","doi-asserted-by":"publisher","unstructured":"Lai W, Yu L. Elevated MicroRNA 183 Impairs Trophoblast Migration and Invasiveness by Downregulating FOXP1 Expression and Elevating GNG7 Expression during Preeclampsia. Mol Cell Biol. 2020;41(1). https:\/\/doi.org\/10.1128\/MCB.00236-20.","DOI":"10.1128\/MCB.00236-20"},{"issue":"2","key":"8105_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1042\/CS20190920","volume":"134","author":"K Schlosser","year":"2020","unstructured":"Schlosser K, Kaur A, Dayan N, Stewart DJ, Pilote L, Delles C. Circulating miR-206 and Wnt-signaling are associated with cardiovascular complications and a history of preeclampsia in women. Clin Sci (Lond). 2020;134(2):87\u2013101.","journal-title":"Clin Sci (Lond)"},{"key":"8105_CR59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejogrb.2020.03.035","volume":"248","author":"J Tian","year":"2020","unstructured":"Tian J, Liu Y, Hu M, Zheng Y, Xu P, Zhang L, Liao J, Wu Y, Wen L, Tong C, et al. Upregulated LncZBTB39 in pre-eclampsia and its effects on trophoblast invasion and migration via antagonizing the Inhibition of miR-210 on THSD7A expression. Eur J Obstet Gynecol Reprod Biol. 2020;248:164\u201371.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"8105_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/uog.1834","volume":"25","author":"KR Wojdemann","year":"2005","unstructured":"Wojdemann KR, Shalmi AC, Christiansen M, Larsen SO, Sundberg K, Brocks V, Bang J, Norgaard-Pedersen B, Tabor A. Improved first-trimester down syndrome screening performance by Lowering the false-positive rate: a prospective study of 9941 low-risk women. Ultrasound Obstet Gynecol. 2005;25(3):227\u201333.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"8105_CR61","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/pd.2180","volume":"29","author":"J Laigaard","year":"2009","unstructured":"Laigaard J, Pedersen NG, Larsen SO, Hedley PL, Wojdemann K, Gjerris AC, Shalmi AC, Sundberg K, Tabor A, Christiansen M. ADAM12 in first trimester maternal serum from pregnancies conceived by assisted reproduction techniques (ART). Prenat Diagn. 2009;29(6):628\u20139.","journal-title":"Prenat Diagn"},{"issue":"1","key":"8105_CR62","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/01.AOG.0000165829.65319.65","volume":"106","author":"J Laigaard","year":"2005","unstructured":"Laigaard J, Sorensen T, Placing S, Holck P, Frohlich C, Wojdemann KR, Sundberg K, Shalmi AC, Tabor A, Norgaard-Pedersen B, et al. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol. 2005;106(1):144\u20139.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"8105_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/life13010130","volume":"13","author":"VE de Knegt","year":"2023","unstructured":"de Knegt VE, Hedley PL, Eltvedt AK, Placing S, Wojdemann K, Shalmi AC, Rode L, Kanters JK, Sundberg K, Tabor A, et al. First-Trimester maternal serum adiponectin\/leptin ratio in Pre-Eclampsia and fetal growth. Life. 2023;13(1):130.","journal-title":"Life"},{"issue":"6","key":"8105_CR64","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/pd.1998","volume":"28","author":"P Hedley","year":"2008","unstructured":"Hedley P, Christiansen M. Serum leptin in first-trimester down syndrome pregnancies. Prenat Diagn. 2008;28(6):475\u20137.","journal-title":"Prenat Diagn"},{"issue":"2","key":"8105_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/pd.2337","volume":"30","author":"PL Hedley","year":"2010","unstructured":"Hedley PL, Placing S, Wojdemann K, Carlsen AL, Shalmi AC, Sundberg K, Tabor A, Christiansen M. Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia. Prenat Diagn. 2010;30(2):103\u20139.","journal-title":"Prenat Diagn"},{"key":"8105_CR66","unstructured":"Hypertension. og pr\u00e6eklampsi. https:\/\/static1.squarespace.com\/static\/5467abcce4b056d72594db79\/t\/5bac84e7652dea0a1b5fb489\/1538032877105\/180924+PE-guideline-final+sandbjerg.pdf."},{"issue":"5","key":"8105_CR67","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.37890","volume":"65","author":"AL Carlsen","year":"2013","unstructured":"Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A, Harris CC, Hellmark T, Segelmark M, Jacobsen S, et al. Circulating MicroRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013;65(5):1324\u201334.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8105_CR68","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3390\/ijms21061973","volume":"21","author":"MA Ochoa-Bernal","year":"2020","unstructured":"Ochoa-Bernal MA, Fazleabas AT. Physiologic events of embryo implantation and decidualization in human and Non-Human primates. Int J Mol Sci. 2020;21(6):1973.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"8105_CR69","doi-asserted-by":"publisher","first-page":"R259","DOI":"10.1530\/REP-17-0603","volume":"155","author":"H Hayder","year":"2018","unstructured":"Hayder H, O\u2019Brien J, Nadeem U, Peng C. MicroRNAs: crucial regulators of placental development. Reproduction. 2018;155(6):R259\u201371.","journal-title":"Reproduction"},{"issue":"5","key":"8105_CR70","first-page":"4442","volume":"22","author":"J Miao","year":"2020","unstructured":"Miao J, Zhu Y, Xu L, Huang X, Zhou X. miR\u2013181b\u20135p inhibits trophoblast cell migration and invasion through targeting S1PR1 in multiple abnormal trophoblast invasion\u2013related events. Mol Med Rep. 2020;22(5):4442\u201351.","journal-title":"Mol Med Rep"},{"key":"8105_CR71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fendo.2018.00100","volume":"9","author":"M Liu","year":"2018","unstructured":"Liu M, Wang Y, Lu H, Wang H, Shi X, Shao X, Li YX, Zhao Y, Wang YL. miR-518b enhances human trophoblast cell proliferation through targeting Rap1b and activating Ras-MAPK signal. Front Endocrinol. 2018;9:100.","journal-title":"Front Endocrinol"},{"issue":"6","key":"8105_CR72","doi-asserted-by":"publisher","first-page":"E1051","DOI":"10.1210\/jc.2011-3131","volume":"97","author":"W Wang","year":"2012","unstructured":"Wang W, Feng L, Zhang H, Hachy S, Satohisa S, Laurent LC, Parast M, Zheng J, Chen DB. Preeclampsia up-regulates angiogenesis-associated MicroRNA (i.e., miR-17, -20a, and \u2013\u200920b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab. 2012;97(6):E1051\u20131059.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"8105_CR73","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/ijms22052313","volume":"22","author":"A Ali","year":"2021","unstructured":"Ali A, Hadlich F, Abbas MW, Iqbal MA, Tesfaye D, Bouma GJ, Winger QA, Ponsuksili S. MicroRNA-mRNA networks in pregnancy complications: A comprehensive downstream analysis of potential biomarkers. Int J Mol Sci. 2021;22(5):2313.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8105_CR74","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/labinvest.2013.157","volume":"94","author":"S Tam","year":"2014","unstructured":"Tam S, de Borja R, Tsao MS, McPherson JD. Robust global MicroRNA expression profiling using next-generation sequencing technologies. Lab Invest. 2014;94(3):350\u20138.","journal-title":"Lab Invest"},{"issue":"4","key":"8105_CR75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jpha.2019.05.004","volume":"9","author":"J Ye","year":"2019","unstructured":"Ye J, Xu M, Tian X, Cai S, Zeng S. Research advances in the detection of MiRNA. J Pharm Anal. 2019;9(4):217\u201326.","journal-title":"J Pharm Anal"},{"issue":"3","key":"8105_CR76","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/1535370217731291","volume":"243","author":"IP Pogribny","year":"2018","unstructured":"Pogribny IP. MicroRNAs as biomarkers for clinical studies. Exp Biol Med. 2018;243(3):283\u201390.","journal-title":"Exp Biol Med"},{"issue":"4","key":"8105_CR77","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.111.00087","volume":"61","author":"AH Baker","year":"2013","unstructured":"Baker AH, Delles C. Is microRNA-376c a biomarker or mediator of preeclampsia? Hypertension. 2013;61(4):767\u20139.","journal-title":"Hypertension."},{"key":"8105_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41420-020-0269-0","volume":"6","author":"Q Li","year":"2020","unstructured":"Li Q, Han Y, Xu P, Yin L, Si Y, Zhang C, Meng Y, Feng W, Pan Z, Gao Z, et al. Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia. Cell Death Discov. 2020;6:35.","journal-title":"Cell Death Discov"},{"key":"8105_CR79","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.gene.2017.07.010","volume":"627","author":"DS Jairajpuri","year":"2017","unstructured":"Jairajpuri DS, Malalla ZH, Mahmood N, Almawi WY. Circulating MicroRNA expression as predictor of preeclampsia and its severity. Gene. 2017;627:543\u20138.","journal-title":"Gene"},{"issue":"6","key":"8105_CR80","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/uog.17455","volume":"49","author":"N O\u2019Gorman","year":"2017","unstructured":"O\u2019Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, Carbone IF, Dutemeyer V, Fiolna M, Frick A, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756\u201360.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"8105_CR81","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/uog.6244","volume":"32","author":"R Akolekar","year":"2008","unstructured":"Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. Maternal serum placental growth factor at 11\u2009+\u20090 to 13\u2009+\u20096 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(6):732\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"8105_CR82","doi-asserted-by":"publisher","first-page":"e11226","DOI":"10.1016\/j.heliyon.2022.e11226","volume":"8","author":"M Danielli","year":"2022","unstructured":"Danielli M, Thomas RC, Gillies CL, Hu J, Khunti K, Tan BK. Blood biomarkers to predict the onset of pre-eclampsia: A systematic review and meta-analysis. Heliyon. 2022;8(11):e11226.","journal-title":"Heliyon"},{"key":"8105_CR83","doi-asserted-by":"publisher","first-page":"946433","DOI":"10.3389\/fcvm.2022.946433","volume":"9","author":"S Zhao","year":"2022","unstructured":"Zhao S, Yin C, Zhai Y, Jia Z, Su S, Lu Y, Meng L, Li C, Liu X, Cong Y, et al. Serum peptidomic screening identified Circulating peptide biomarkers predictive for preeclampsia. Front Cardiovasc Med. 2022;9:946433.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"8105_CR84","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/10641955.2014.913615","volume":"34","author":"M Christiansen","year":"2015","unstructured":"Christiansen M, Hedley PL, Placing S, Wojdemann KR, Carlsen AL, Jorgensen JM, Gjerris AC, Shalmi AC, Rode L, Sundberg K, et al. Maternal serum resistin is reduced in first trimester preeclampsia pregnancies and is a marker of clinical severity. Hypertens Pregnancy. 2015;34(4):422\u201333.","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"8105_CR85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1515\/cclm-2017-0356","volume":"56","author":"CP De Villiers","year":"2018","unstructured":"De Villiers CP, Hedley PL, Placing S, W\u00f8jdemann KR, Shalmi A-C, Carlsen AL, Rode L, Sundberg K, Tabor A, Christiansen M. Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia. Clin Chem Lab Med. 2018;56(1):65\u201374.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"8105_CR86","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/pedi.12964","volume":"21","author":"C Frithioff-B\u00f8js\u00f8e","year":"2020","unstructured":"Frithioff-B\u00f8js\u00f8e C, Lund MA, Lausten\u2010Thomsen U, Hedley PL, Pedersen O, Christiansen M, Baker JL, Hansen T, Holm JC. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity. Pediatr Diabetes. 2020;21(2):194\u2013202.","journal-title":"Pediatr Diabetes"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08105-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08105-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08105-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:08:49Z","timestamp":1759316929000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-08105-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8105"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08105-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Copenhagen First Trimester Screening study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Scientific ethics committee of the cities of Copenhagen and Frederiksberg (No. (KF) 01-288\/97) and the Data Protection Agency. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"995"}}